Authors
Latest:
AAO 2024: Main takeaways from the Zoster Eye Disease studyResearch indicates suppressive valacyclovir could help patients avoid keratitis and iritis flare-ups
Latest:
Focusing on functional vision with monofocal lensesQuantitative and qualitative improvement in IOL design
Latest:
Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye diseaseA short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
Latest:
Cross-linking in paediatric patients: The case for treating keratoconus without waiting for disease progressionThe case for treating keratoconus without waiting for disease progression
Latest:
TEASE-3 study: Positive interim data are reported for Stargardt drugGildeuretinol halts Stargardt disease progression, study results indicate
Latest:
Distorted corneas: How to regularise them with minimally invasive surgerySequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
Latest:
Gene therapy research ushers in new therapy options for retinal diseasesFoundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.
Latest:
Risks and management of diabetic retinopathy in paediatric patientsDiabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Latest:
The impact of landmark studies on clinical practice in glaucomaLandmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Latest:
Landscape of genetic therapies for USH2A-related retinitis pigmentosaIncreasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
The shifting landscape of conjunctival hyperemiaEuropean patients navigate new therapies and market change-ups
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
Keratoconus: Intrastromal implantation of fresh human lenticulesStromal regeneration seems possible in patients with keratoconus.
Latest:
Paying attention to ocular surface disease preoperatively mattersLook for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
Latest:
The “fourth dimension” of home monitoringA longitudinal, AI-based approach to fluid quantification
Latest:
Understanding the molecular mechanisms underlying cataract developmentA greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.
Latest:
For younger patients with mid-range myopia, consider phakic IOLsThe implantable lenses can offer an advantage over laser surgery
Latest:
How to use topography-guided laser procedures to treat keratoconusTopography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Extended depth-of-field IOLs: Clarification of current nomenclatureClinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.
Latest:
The CHAMP clinical trial and NVK002 for controlling paediatric myopiaDetermining the medication’s safety and efficacy for paediatric patients
Latest:
A new route to reducing IOPTo date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Surgical management of posterior uveitis in childrenVitrectomy is a tool that can help surgeons curb complications
